Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
β Scribed by Jeng-Wei Lu, Yueh-Min Lin, Jan-Gowth Chang, Kun-Tu Yeh, Rong-Ming Chen, Jeffrey J. P. Tsai, Wei-Wen Su, Rouh-Mei Hu
- Book ID
- 118821752
- Publisher
- Springer US
- Year
- 2013
- Tongue
- English
- Weight
- 530 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We analyzed the expression and amplification of cyclin D1 and CDK4 genes in ovarian carcinomas. Northern blot analysis revealed overexpression of cyclin D1 in 12 of 65 (18%) ovarian carcinomas while CDK4 was overexpressed in 7 of 48 cases (14%). None of the tumors showed amplification of any of the
## Abstract Cyclin D1 is a wellβknown cell cycle regulator. Recently, its proβsurvival function has been revealed in several tumors. Because increasing expression of cyclin D1 is a common event in oral squamous cell carcinoma (OSCC) and has been correlated with cisplatin resistance, we investigated